Biochemical evidence on positive effects of rolipram a phosphodiesterase-4 inhibitor in malathion-induced toxic stress in rat blood and brain mitochondria

Pesticide Biochemistry and Physiology

Volumn 98, Issue 1, 2010, Pages 135-143

  Rezvanfar, Mohammad Ali ^a   Rezvanfar, Mohammad Amin ^a   Ranjbar, Akram ^a   Baeeri, Maryam ^a   Mohammadirad, Azadeh ^a   Abdollahi, Mohammad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Brain mitochondria; Lipid peroxidation; Malathion; Oxidative stress; Rolipram

Indexed keywords

ANIMALIA; RATTUS;

EID: 77954953187     PISSN: 00483575     EISSN: 10959939     Source Type: Journal    
DOI: 10.1016/j.pestbp.2010.06.001     Document Type: Article

References (85)

1. Abdollahi M., Jalali N., Sabzevari O., Hosseini R., Ghanea T. A retrospective study of poisoning in Tehran. J. Toxicol. Clin. Toxicol. 1997, 35:387-393.
2. Abdollahi M., Jalali N., Sabzevari O., Nikfar S., Fallahpour M. Pesticide poisoning during an 18-month period (1995-1997) in Tehran, Iran. Irn. J. Med. Sci. 1999, 24:77-81.
3. Moghadamnia A.A., Abdollahi M. An epidemiological study of poisoning in northern Islamic Republic of Iran. East. Mediterr. Health J. 2002, 8:1-6.
4. Abdollahi M., Kebriaeezadeh A., Pirdehghan F., Akhgari M., Jannat B., Jalali N. Cholinesterase activity in saliva, plasma and erythrocytes of the Iranian population. Toxicol. Lett. 1995, 78:15. 15(1).
5. Abdollahi M., Jafari A., Jalali N. Chronic toxicity in organophosphate exposed workers. M.J.I.R.I. 1995, 9:221-225.
6. Abdollahi M., Jafari A., Jalali N., Balali M., Kebriaeezadeh A., Nikfar S. A new approach to the efficacy of oximes in the management of acute organophosphate poisoning. Irn. J. Med. Sci. 1995, 20:105-109.
7. Abdollahi M., Balali M., Akhgari M., Jannat B., Kebriaeezadeh A., Nikfar S. A survey of cholinesterase activity in healthy and organophosphate-exposed populations. Irn. J. Med. Sci. 1996, 21:63-66.
8. Abdollahi M., Ranjbar A., Shadnia S., Nikfar S., Rezaiee A. Pesticides and oxidative stress: a review. Med. Sci. Monit. 2004, 10:144-147.
9. Abdollahi M., Mostafalou S., Pournourmohammadi S., Shadnia S. Oxidative stress and cholinesterase inhibition in saliva and plasma of rats following subchronic exposure to malathion. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2004, 137:29-34.
10. Akhgari M., Abdollahi M., Kebryaeezadeh A., Hosseini R., Sabzevari O. Biochemical evidence for free radical-induced lipid peroxidation as a mechanism for subchronic toxicity of malathion in blood and liver of rats. Hum. Exp. Toxicol. 2003, 22:205-211.
11. Shadnia S., Azizi E., Hosseini R., Khoei S., Fouladdel S., Pajoumand A., Jalali N., Abdollahi M. Evaluation of oxidative stress and genotoxicity in organophosphorus insecticide formulators. Hum. Exp. Toxicol. 2005, 9:439-445.
12. Ranjbar A., Pasalar P., Abdollahi M. Induction of oxidative stress and acetylcholinesterase inhibition in organophosphorous pesticide manufacturing workers. Hum. Exp. Toxicol. 2002, 21:179-182.
13. Milatovic R.C., Gupta M., Aschner Anticholinesterase toxicity and oxidative stress. Sci. World J. 2006, 6:295-310.
14. WHO Lindane in Drinking-water. Background Document for Preparation of WHO Guidelines for Drinking-water Quality, Geneva, World Health Organization, (WHO/SDE/WSH/03.04/102), 2003.
15. Banerjee B.D., Seth V., Bhattacharya A., Pasha S.T., Chakraborty A.K. Biochemical effects of some pesticides on lipid peroxidation and free-radical scavengers. Toxicol. Lett. 1999, 107:33-47.
16. Jamshidi H.R., Ghahremani M.H., Ostad N., Sharifzadeh M., Dehpour A.R., Abdollahi M. Effects of diazinon on the activity and gene expression of mitochondrial glutamate dehydrogenase from rat pancreatic Langerhans islets. Pest. Biochem. Physiol. 2009, 93:23-27.
17. Fortunato J.J., Feier G., Vitali A.M., Petronilho F.C., Dal-Pizzol F., Quevedo J. Malathion-induced oxidative stress in rat brain regions. Neurochem. Res. 2006, 31:671-678.
18. Fortunato J.J., Agostinho F.R., Reus G.Z., Petronilho F.C., Dal-Pizzol F., Quevedo J. Lipid peroxidative damage on malathion exposure in rats. Neurotoxicol. Res. 2006, 9:23-28.
19. Vidair C.A. Age dependence of organophosphate and carbamate neurotoxicity in the postnatal rat: extrapolation to the human. Toxicol. Appl. Pharmacol. 2004, 196:287-302.
20. Brocardo P.S., Pandolfo P., Takahashi R.N., Rodrigues A.L., Dafre A.L. Antioxidant defenses and lipid peroxidation in the cerebral cortex and hippocampus following acute exposure to malathion and/or zinc chloride. Toxicology 2005, 207:283-291.
21. da Silva A.P., Meotti F.C., Santos A.R., Farina M. Lactational exposure to malathion inhibits brain acetylcholinesterase in mice. Neuro Toxicol. 2006, 27:1101-1105.
22. Hazarika A., Sarkar S.N., Hajare S., Kataria M., Malik J.K. Influence of malathion pretreatment on the toxicity of anilofos in male rats: a biochemical interaction study. Toxicology 2003, 185:1-8.
23. Trevisan R., Uliano-Silva M., Pandolfo P., Franco J.L., Brocardo P.S., Santos A.R., Farina M., Rodrigues A.L., Takahashi R.N., Dafre A.L. Antioxidant and acetylcholinesterase response to repeated malathion exposure in rat cerebral cortex and hippocampus. Basic Clin. Pharmacol. Toxicol. 2008, 102:365-369.
24. Delgado E.H., Streck E.L., Quevedo J.L., Dal-Pizzol F. Mitochondrial respiratory dysfunction and oxidative stress after chronic malathion exposure. Neurochem. Res. 2006, 31:1021-1025.
25. Leuner K., Hauptmann S., Abdel-Kader R., Scherping I., Keil U., Strosznajder J.B., Eckert A., Muller W.E. Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease?. Antioxid. Redox Signal. 2007, 9:1659-1675.
26. Liu R., Liu I.Y., Bi X., Thompson R.F., Doctrow S.R., Malfroy B., Baudry M. Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics. Proc. Natl. Acad. Sci. USA 2003, 100:8526-8531.
27. Yurumez M., Cemek Y., Yavuz Y.O., Birdane M.E., Büyükokuroĝlu Beneficial effect of N-acetylcysteine against organophosphate toxicity in mice. Biol. Pharm. Bull. 2007, 30:490-494.
28. Shadnia Sh., Dasgar M., Taghikhani S., Mohammadirad A., Abdollahi M. Protective effects of a-tocopherol and N-acetyl-cysteine on diazinon-induced oxidative stress and acetylcholinesterase inhibition in rats. Toxicol. Mech. Methods 2007, 17:1-8.
29. Büyükokuroĝlu M., Cemek Y., Yurumez Y., Yavuz A., Aslan A. Antioxidative role of melatonin in organophosphate toxicity in rats. Cell. Biol. Toxicol. 2008, 24:151-158.
30. Azadbar M., Ranjbar A., Hosseini-Tabatabaei A., Golestani A., Baeeri M., Sharifzadeh M., Abdollahi M. Interaction of phosphodiesterase 5 inhibitor with malathion on rat brain mitochondrial-bound hexokinase activity. Pestic. Biochem. Physiol. 2009, 95:121-125.
31. Turner N.C., Wood U., Burns F.M., Gueremy T., Souness J.E. The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages. Br. J. Pharmacol. 1993, 108:876-883.
32. Mueller H., Montoya B., Sklar L.A. Reversal of inhibitory pathways in neutrophils by protein kinase antagonists: a rational approach to the restoration of depressed cell function?. J. Leukoc. Biol. 1992, 52:400-406.
33. Kim E.J., Kwon K.J., Park J.Y., Lee S.H., Moon C.H., Baik E.J. Neuroprotective effects of prostaglandin E2 or cAMP against microglial and neuronal free radical mediated toxicity associated with inflammation. J. Neurosci. Res. 2002, 70:97-107.
34. Schütte H., Schell A., Schafer C., Ghofrani A., Theo Schermuly R., Seeger W., Grimminger F. Subthreshold doses of nebulized prostacyclin and rolipram synergistically protect against lung ischemia-reperfusion. Transplantation 2003, 75:814-882.
35. Kyoi T., Noda K., Oka M., Ukai Y. Irsogladine an anti-ulcer drug suppresses superoxide production by inhibiting phosphodiesterase type 4 in human neutrophils. Life Sci. 2004, 76:71-83.
36. Souza D.G., Cassali G.D., Poole S., Teixeira M.M. Effects of inhibition of PDE4 and TNF-alpha on local and remote injuries following ischemia and reperfusion injury. Br. J. Pharmacol. 2001, 134:985-994.
37. Chi Z.L., Hayasaka S., Zhang X.Y., Hayasaka Y., Cui H.S. Effects of rolipram a selective inhibitor of type 4 phosphodiesterase, on lipopolysaccharide-induced uveitis in rats. Invest. Ophthalmol. Vis. Sci. 2004, 45:2497-2502.
38. J.B. Mendes, M.A. Rocha, F.A. Araújo, S.A. Moura, M.A. Ferreira, S.P. Andrade, Differential effects of rolipram on chronic subcutaneous inflammatory angiogenesis and on peritoneal adhesion in mice. Microvasc. Res. (2009) Sep 2. [Epub ahead of print] PubMed PMID: 19732781.
39. Alvarez B., Radi R. Peroxynitrite reactivity with amino acids and proteins. Amino Acids 2003, 25:295-311.
40. Imam S.Z., Islam F., Itzhak Y., Slikker W., Ali S.F. Prevention of dopaminergic neurotoxicity by targeting nitric oxide and peroxynitrite: implications for the prevention of methamphetamine-induced neurotoxic damage. Ann. N.Y. Acad. Sci. 2000, 914:157-171.
41. Imam S.Z., Newport G.D., Itzhak Y., Cadet J.L., Islam F., Slikker W., Ali S.F. Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or over expressing copper-zinc superoxide dismutase. J. Neurochem. 2001, 76:745-749.
42. Torreilles F., Salman-Tabcheh S., Guérin M., Torreilles J. Neurodegenerative disorders: the role of peroxynitrite. Brain Res. Brain Res. Rev. 1999, 30:153-163.
43. Massicotte C., Knight K., Van der Schyf C.J., Jortner B.S., Ehrich M. Effects of organophosphorus compounds on ATP production mitochondrial integrity in cultured cells. Neurotoxicol. Res. 2005, 7:203-217.
44. Chauhan V., Chauhan A. Oxidative stress in Alzheimer's disease. Pathophysiology 2006, 13:195-208.
45. Kale M., Rathore N., John S., Bhatnagar D. Lipid peroxidative damage on pyrethroid exposure and alterations in antioxidant status in rat erythrocytes: a possible involvement of reactive oxygen species. Toxicol. Lett. 1999, 105:197-205.
46. Halliwell B. The antioxidant paradox. Lancet 2000, 355:1179-1180.
47. Ahmed R.S., Seth V., Pasha S.T., Banerjee B.D. Influence of dietary ginger (Zingiber officinales Rosc) on oxidative stress induced by malathion in rats. Food Chem. Toxicol. 2000, 38:443-450.
48. John S., Kale M., Rathore N., Bhatnagar D. Protective effect of vitamin E in dimethoate and malathion induced oxidative stress in rat erythrocytes. J. Nutr. Biochem. 2001, 12:500-504.
49. Prakasam A., Sethupathy S., Lalitha S. Plasma and RBCs antioxidant status in occupational male pesticide sprayers. Clin. Chim. Acta 2001, 310:107-112.
50. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J. Neurochem. 2006, 97:1634-1658.
51. Bivalacqua T.J., Sussan T.E., Gebska M.A., Strong T.D., Berkowitz D.E., Biswal S., Burnett A.L., Champion H.C. Sildenafil inhibits superoxide formation and prevents endothelial dysfunction in a mouse model of secondhand smoke induced erectile dysfunction. J. Urol. 2009, 181:899-906.
52. Burdi R., Rolland J.F., Fraysse B., Litvinova K., Cozzoli A., Giannuzzi V., Liantonio A., Camerino G.M., Sblendorio V., Capogrosso R.F., Palmieri B., Andreetta F., Confalonieri P., De Benedictis L., Montagnani M., De Luca A. Multiple pathological events in exercised dystrophic mdx mice are targeted by pentoxifylline: outcome of a large array of in vivo and ex vivo tests. J. Appl. Physiol. 2009, (90985.2008v1).
53. Uzun H., Konukoglu D., Nuri M.K., Ersoy E.Y., Ozçevik S., Yavuz N. The effects of sildenafil citrate on ischemic colonic anastomotic healing in rats: its relationship between nitric oxide and oxidative stress. World J. Surg. 2008, 32:2107-2113.
54. Gur S., Sikka S.C., Hellstrom W.J. Novel phosphodiesterase-5 (PDE5) inhibitors in the alleviation of erectile dysfunction due to diabetes and ageing-induced oxidative stress. Expert. Opin. Investig. Drugs 2008, 17:855-864.
55. Beheshtian A., Salmasi A.H., Payabvash S., Kiumehr S., Ghazinezami B., Rahimpour S., Tavangar S.M., Dehpour A.R. Protective effects of sildenafil administration on testicular torsion/detorsion damage in rats. World J. Urol. 2008, 26:197-202.
56. Behr-Roussel D., Oudot A., Caisey S., Coz O.L., Gorny D., Bernabé J., Wayman C., Alexandre L., Giuliano F.A. Daily treatment with sildenafil reverses endothelial dysfunction and oxidative stress in an animal model of insulin resistance. Eur. Urol. 2008, 53:1272-1280.
57. Masood A., Nadeem A., Mustafa S.J., O'Donnell J.M. Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice. J. Pharmacol. Exp. Ther. 2008, 326:369-379.
58. Keshavarzian A., Mutlu E., Guzman J.P., Forsyth C., Banan A. Phosphodiesterase 4 inhibitors and inflammatory bowel disease: emerging therapies in inflammatory bowel disease. Expert. Opin. Invest. Drugs 2007, 16:1489-1506.
59. Brown D.M., Hutchison L., Donaldson K., MacKenzie S.J., Dick C.A., Stone V. The effect of oxidative stress on macrophages and lung epithelial cells: the role of phosphodiesterases 1 and 4. Toxicol. Lett. 2007, 168:1-6.
60. Hoseini S., Esmaily H., Mohammadirad A., Abdollahi M. Effects of sildenafil a phosphodiesterase 5 inhibitor on rat liver cell key enzymes of gluconeogenesis and glycogenolysis. Int. J. Pharmacol. 2006, 2:280-285.
61. Dávila-Esqueda M.E., Vertiz-Hernández A.A., Martínez-Morales F. Comparative analysis of the renoprotective effects of pentoxifylline and vitamin E on streptozotocin-induced diabetes mellitus. Ren. Fail. 2005, 27:115-122.
62. Milani E., Nikfar S., Khorasani R., Zamani M.J., Abdollahi M. Reduction of diabetes-induced oxidative stress by phosphodiesterase inhibitors in rats. Comp. Biochem. Physiol. C Comp. Pharmacol. Toxicol. 2005, 140:251-255.
63. Mohamed H.E., Asker M.E., Ali S.I., el-Fattah T.M. Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4. J. Pharm. Pharmacol. 2004, 56:757-768.
64. Abdollahi M., Bahreini-Moghadam A., Emami B., Fooladian F., Zafari K. Increasing intracellular cAMP and cGMP inhibits cadmium-induced oxidative stress in rat submandibular saliva. Comp. Biochem. Physiol. 2003, 135:331-336.
65. Abdollahi M., Chan T.S., Subrahmanyam V., Obrien P.J. Effects of phosphodiesterase 3,4,5 inhibitors on hepatocyte cAMP levels, glycogenolysis, gluconeogenesis and susceptibility to a mitochondrial toxin. Mol. Cell. Biochem. 2003, 252:205-211.
66. Abdollahi M., Fooladian F., Emami B., Zafari K., Bahreini-Moghadam A. Protection by sildenafil and theophylline of lead acetate induced oxidative stress in rat submandibular gland and saliva. Hum. Exp. Toxicol. 2003, 22:587-592.
67. Abdollahi M., Dehpour A.R., Kazemian P. Interaction of cadmium with nitric oxide in rat submandibulary gland function. Pharmacol. Res. 2000, 42:591-597.
68. Abdollahi M., Dehpour A.R., Shafayee F. l-Arginine/nitric oxide pathway and interaction with lead acetate on rat submandibulary gland function. Pharmacol. Toxicol. 2000, 87:198-203.
69. Ghafour-Rashidi Z., Dermenaki-Farahani E., Aliahmadi A., Esmaily H., Mohammadirad A., Ostad S.N., Abdollahi M. Protection by cAMP and cGMP phosphodiesterase inhibitors of diazinon-induced hyperglycemia and oxidative/nitrosative stress in rat Langerhans islets cells: molecular evidence for involvement of noncholinergic mechanisms. Pestic. Biochem. Physiol. 2007, 87:261-270.
70. Panahi P., Vosough-Ghanbari S., Pournourmohammadi S., Ostad S.N., Nikfar S.H., Minaie B., Abdollahi M. Stimulatory effects of malathion on the key enzymes activities of insulin secretion in Langerhans islets glutamate dehydrogenase and glucokinase. Toxicol. Mech. Methods 2006, 16:161-167.
71. Zhang B., Yang L., Konishi Y., Maeda N., Sakanaka M., Tanaka J. Suppressive effects of phosphodiesterase type IV inhibitors on rat cultured microglial cells: comparison with other types of camp-elevating agents. Neuropharmacology 2002, 42:262-269.
72. Koschorreck S., Wenzel F., Fuhrmann M., Racke K. Effects of phosphodiesterase inhibitors on L-arginine pathways in rat alveolar macrophages. Eur. J. Pharmacol. 2003, 471:229-236.
73. Hosoi R., Ishikawa M., Kobayashi K., Gee A., Yamaguchi M., Inoue O. Effect of rolipram on muscarinic acetylcholine receptor binding in the intact mouse brain. J. Neural. Transm. 2003, 110:363-372.
74. Gong B., Vitolo O.V., Trinchese F., Liu S., Shelanski M., Arancio O. Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J. Clin. Invest. 2004, 114:1624-1634.
75. Itoh T., Tokumura M., Abe K. Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats. Eur. J. Pharmacol. 2004, 498:135-142.
76. Monti B., Berteotti C., Contestabile A. Subchronic rolipram delivery activates hippocampal CREB and arc, enhances retention and slows down extinction of conditioned fear. Neuropsychopharmacology 2006, 31:278-286.
77. Jacob C., Szilagyi C., Allen J.M., Bertrand C., Lagente V. Role of PDE4 in superoxide anion generation through p44/42MAPK regulation: a cAMP and a PKA-independent mechanism. Br. J. Pharmacol. 2004, 143:257-268.
78. Görür S., Celik S., Hakverdi S., Aslantaş O., Erdoĝan S., Aydin M., Ocak S., Namik Kiper A. Preventive effect of rolipram, a phosphodiesterase 4 enzyme inhibitor, on oxidative renal injury in acute ascending pyelonephritis model in rats. Urology 2008, 72:743-748.
79. Chen X.Y., Shao J.Z., Xiang L.X., Liu X.M. Involvement of apoptosis in malathion-induced cytotoxicity in a grass carp (Ctenopharyngodon idellus) cell line. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2006, 142:36-45.
80. Nielson C.P., Crowley J.J., Morgan M.E., Vestal R.E. Polymorphonuclear leukocyte inhibition by therapeutic concentrations of theophylline is mediated by cyclic-3V, 5V-adenosine monophosphate. Am. Rev. Respir. Dis. 1988, 137:25-30.
81. Villagrasa V., Navarrete C., Sanz C., Berto L., Perpina M., Cortijo J., Morcillo E.J. Inhibition of phosphodiesterase IV and intracellular calcium levels in human polymorphonuclear leukocytes. Methods Find. Exp. Clin. Pharmacol. 1996, 18:239-245.
82. Anderson R., Goolam Mahomed A., Theron A.J., Ramafi G., Feldman C. Effect of rolipram and dibutyryl cyclic AMP on resequestration of cytosolic calcium in FMLP-activated human neutrophils. Br. J. Pharmacol. 1998, 124:547-555.
83. Rahimi R., Ghiasi S., Azimi H., Fakhari S., Abdollahi M. A review of the herbal phosphodiesterase inhibitors; future perspective of new drugs. Cytokine 2010, 49:123-129.
84. Grifman M., Arbel A., Ginzberg D., Glick D., Elgavish S., Shaanan B., Soreq H. In vitro phosphorylation of acetylcholinesterase at non-consensus protein kinase A sites enhances the rate of acetylcholine hydrolysis. Brain Res. Mol. Brain Res. 1997, 51:179-187.
85. A. Ranjbar, M.H. Ghahremani, M. Sharifzadeh, A. Golestani, M. Ghazi-Khansari, M. Baeeri, M. Abdollahi. Protection by pentoxifylline of malathion-induced toxic stress and mitochondrial damage in rat brain. Hum. Exp. Toxicol. 1 (2010) [Epub ahead of print].